ADVERSE REACTIONS
Serious adverse reactions are uncommon when verapamil
hydrochloride therapy is initiated with upward dose titration within the
recommended single and total daily dose. See WARNINGS for discussion of
heart failure, hypotension, elevated liver enzymes, AV block, and rapid
ventricular response. Reversible (upon discontinuation of verapamil)
non-obstructive, paralytic ileus has been infrequently reported in association
with the use of verapamil. The following reactions to orally administered
verapamil occurred at rates greater than 1% or occurred at lower rates but
appeared clearly drug-related in clinical trials in 4,954 patients:
Constipation |
7.3% |
Dyspnea |
1.4% |
Dizziness |
3.3% |
Bradycardia |
|
Nausea |
2.7% |
(HRgretwe then 50/min) |
1.4% |
Hypotension |
2.5% |
AV block |
|
Headache |
2.2% |
total (1°, 2°, 3°) |
1.2% |
Edema |
1.9% |
2° and 3° |
0.8% |
CHF,Pulmonary edema |
1.8% |
Rash |
1.2% |
Fatigue |
1.7% |
Flushing |
0.6% |
Elevated liver enzymes(see WARNINGS) |
|
|
|
In clinical trials related to the control of ventricular response in
digitalized patients who had atrial fibrillation or flutter, ventricular rates
below 50 at rest occurred in 15% of patients and asymptomatic hypotension
occurred in 5% of patients.
The following reactions, reported in 1% or less of patients, occurred under
conditions (open trials, marketing experience) where a causal relationship is
uncertain; they are listed to alert the physician to a possible
relationship:
Cardiovascular: angina pectoris, atrioventricular
dissociation, chest pain, claudication, myocardial infarction, palpitations,
purpura (vasculitis), syncope.
Digestive system: diarrhea, dry mouth,
gastrointestinal distress, gingival hyperplasia.
Hemic and lymphatic: ecchymosis or bruising.
Nervous system: cerebrovascular accident,
confusion, equilibrium disorders, insomnia, muscle cramps, paresthesia,
psychotic symptoms, shakiness, somnolence.
Skin: arthralgia and rash, exanthema, hair loss,
hyperkeratosis, maculae, sweating, urticaria, Stevens-Johnson syndrome, erythema
multiforme.
Special senses: blurred vision, tinnitus.
Urogenital: gynecomastia,
galactorrhea/hyperprolactinemia, increased urination, spotty menstruation,
impotence.
Treatment of acute cardiovascular adverse
reactions
The frequency of cardiovascular adverse reactions that require
therapy is rare; hence, experience with their treatment is limited. Whenever
severe hypotension or complete AV block occurs following oral administration of
verapamil, the appropriate emergency measures should be applied immediately;
e.g., intravenously administered norepinephrine bitartrate, atropine sulfate,
isoproterenol hydrochloride (all in the usual doses), or calcium gluconate (10%
injection). In patients with hypertrophic cardiomyopathy (IHSS),
alpha-adrenergic agents (phenylephrine hydrochloride, metaraminol bitartrate, or
methoxamine hydrochloride) should be used to maintain blood pressure, and
isoproterenol and norepinephrine should be avoided. If further support is
necessary, dopamine hydrochloride or dobutamine hydrochloride may be
administered. Actual treatment and dosage should depend on the severity of the
clinical situation and the judgment and experience of the treating physician.
|
REPORTS OF SUSPECTED VERAPAMIL SIDE EFFECTS / ADVERSE REACTIONS
Below is a sample of reports where side effects / adverse reactions may be related to Verapamil. The information is not vetted and should not be considered as verified clinical evidence.
Possible Verapamil side effects / adverse reactions in 49 year old female
Reported by a individual with unspecified qualification from United States on 2011-10-11
Patient: 49 year old female weighing 59.0 kg (129.8 pounds)
Reactions: Nausea, Cardiac Enzymes Increased, Prinzmetal Angina, Drug Interaction, Somnolence, Heart Rate Decreased, Chest Pain, Mitral Valve Incompetence, Blood Pressure Decreased, Vasospasm
Adverse event resulted in: hospitalization
Suspect drug(s):
Verapamil
Other drugs received by patient possibly interacting with the suspect drug: Verapamil
Dosage: 180 mg, unk
Administration route: Oral
Dihydroergotamine Mesylate
Dosage: 1 mg, unk
Nicotine
Dosage: 7 mg, unk
Indication: Smoking Cessation Therapy
Other drugs received by patient: Amantadine HCL; Acetaminophen and Hydrocodone Bitartrate; Gabapentin; Duloxetime Hydrochloride; Morphine Sulfate; Lorazepam; Natalizumab; Haloperidol; Fentanyl
Possible Verapamil side effects / adverse reactions in 88 year old male
Reported by a consumer/non-health professional from United States on 2011-10-13
Patient: 88 year old male
Reactions: Abnormal Behaviour, Gait Disturbance, Cerebrovascular Accident, Fall
Suspect drug(s):
Mirtazapine
Clopidogrel
Pravastatin
Verapamil
Felodipine
Prednisone
Dosage: as needed.
Torsemide
Allopurinol
Possible Verapamil side effects / adverse reactions in 58 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-18
Patient: 58 year old female
Reactions: Toxicity TO Various Agents, Blood Pressure Decreased, Cardiogenic Shock, Blood Glucose Abnormal, Hypokalaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Verapamil
|